Vorinostat and bevacizumab for recurrent glioblastoma episode artwork

EPISODE · Jan 1, 2021 · 32 MIN

Vorinostat and bevacizumab for recurrent glioblastoma

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Vinay Puduvalli, Dr. Ying Yuan

Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in Neuro-Oncology in March 2020

NOW PLAYING

Vorinostat and bevacizumab for recurrent glioblastoma

0:00 32:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 32 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on January 1, 2021.

What is this episode about?

Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!